黄嘌呤氧化酶抑制用于慢性心力衰竭：别嘌醇会成为心力衰竭治疗的下一个进展吗？
Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?
作者信息
Doehner W, Anker S D
出版信息
Heart. 2005 Jun;91(6):707-9. doi: 10.1136/hrt.2004.057190.
Abstract
A substantial body of evidence has accumulated to suggest a role for the xanthine oxidase metabolic pathway in the pathophysiology of chronic heart failure and other cardiovascular diseases.
摘要
大量证据已积累起来，表明黄嘌呤氧化酶代谢途径在慢性心力衰竭和其他心血管疾病的病理生理学中发挥作用。
相似文献
1
Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?
Heart. 2005 Jun;91(6):707-9. doi: 10.1136/hrt.2004.057190.
2
The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol-study protocol.
Clin Exp Nephrol. 2018 Dec;22(6):1379-1386. doi: 10.1007/s10157-018-1599-6. Epub 2018 Jun 18.
3
Can Xanthine Oxidase Inhibitors Improve Cardiac Function in Patients With Chronic Heart Failure?
Int Heart J. 2016 Dec 2;57(6):661-662. doi: 10.1536/ihj.16-480. Epub 2016 Nov 4.
4
Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress.
Vasc Health Risk Manag. 2009;5(1):265-72. doi: 10.2147/vhrm.s4265. Epub 2009 Apr 8.
5
Allopurinol and endothelial function in heart failure: future or fantasy?
Circulation. 2002 Jul 9;106(2):173-5. doi: 10.1161/01.cir.0000024270.37833.f9.
6
Xanthine oxidase inhibition and heart failure: novel therapeutic strategy for ventricular dysfunction?
Circ Res. 2006 Feb 3;98(2):169-71. doi: 10.1161/01.RES.0000204557.09610.01.
7
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.
Pharmacol Rev. 2006 Mar;58(1):87-114. doi: 10.1124/pr.58.1.6.
8
Xanthine oxidase inhibitors: an emerging class of drugs for heart failure.
Eur Heart J. 2005 Aug;26(15):1458-60. doi: 10.1093/eurheartj/ehi321. Epub 2005 May 25.
9
Pharmacotherapy: Xanthine oxidase inhibition for relief of angina pectoris.
Nat Rev Cardiol. 2010 Nov;7(11):603-4. doi: 10.1038/nrcardio.2010.143.
10
Xanthine oxidase inhibitors the unappreciated treatment for heart failure.
Cardiovasc Hematol Disord Drug Targets. 2007 Dec;7(4):291-4. doi: 10.2174/187152907782793563.
引用本文的文献
1
The Effect of High-dose Allopurinol Pretreatment on Inflammatory Biomarkers and Post-revascularization Coronary Blood Flow in Non-STEMI Patients: A Randomized Double Blind Clinical Trial.
ARYA Atheroscler. 2023 Jul;19(4):1-10. doi: 10.48305/arya.2022.11886.2722.
2
The cardiac molecular setting of metabolic syndrome in pigs reveals disease susceptibility and suggests mechanisms that exacerbate COVID-19 outcomes in patients.
Sci Rep. 2021 Oct 5;11(1):19752. doi: 10.1038/s41598-021-99143-w.
3
Associations of serum uric acid level and gout with cardiac structure, function and sex differences from large scale asymptomatic Asians.
PLoS One. 2020 Jul 20;15(7):e0236173. doi: 10.1371/journal.pone.0236173. eCollection 2020.
4
Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout.
PLoS One. 2020 Jun 23;15(6):e0234909. doi: 10.1371/journal.pone.0234909. eCollection 2020.
5
A double blind placebo controlled randomized trial of the effect of acute uric acid changes on inflammatory markers in humans: A pilot study.
PLoS One. 2017 Aug 7;12(8):e0181100. doi: 10.1371/journal.pone.0181100. eCollection 2017.
6
Left ventricular ejection fraction as therapeutic target: is it the ideal marker?
Heart Fail Rev. 2017 Nov;22(6):641-655. doi: 10.1007/s10741-017-9624-5.
7
High serum uric acid levels may increase mortality and major adverse cardiovascular events in patients with acute myocardial infarction.
Saudi Med J. 2017 Jun;38(6):577-585. doi: 10.15537/smj.2017.6.17190.
8
CVD and Oxidative Stress.
J Clin Med. 2017 Feb 20;6(2):22. doi: 10.3390/jcm6020022.
9
Uric acid: where are we?
J Clin Hypertens (Greenwich). 2013 Jan;15(1):5-6. doi: 10.1111/jch.12034. Epub 2012 Nov 26.
10
Effects of Greek legume plant extracts on xanthine oxidase, catalase and superoxide dismutase activities.
J Physiol Biochem. 2012 Mar;68(1):37-45. doi: 10.1007/s13105-011-0117-z. Epub 2011 Oct 8.
本文引用的文献
1
Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure.
Heart. 2005 Jun;91(6):749-53. doi: 10.1136/hrt.2004.040477.
2
Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III - IV congestive heart failure.
Expert Opin Investig Drugs. 2004 Nov;13(11):1509-16. doi: 10.1517/13543784.13.11.1509.
3
Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?
Circulation. 2004 Oct 12;110(15):2175-9. doi: 10.1161/01.CIR.0000144303.24894.1C. Epub 2004 Oct 4.
4
Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk.
Am J Cardiol. 2004 Oct 1;94(7):932-5. doi: 10.1016/j.amjcard.2004.06.032.
5
Beta-blockers for chronic heart failure: surviving longer but feeling better?
Int J Cardiol. 2003 Nov;92(1):1-8. doi: 10.1016/s0167-5273(03)00050-0.
6
Molecular identification of a danger signal that alerts the immune system to dying cells.
Nature. 2003 Oct 2;425(6957):516-21. doi: 10.1038/nature01991. Epub 2003 Sep 7.
7
Effect of allopurinol pretreatment on free radical generation after primary coronary angioplasty for acute myocardial infarction.
J Cardiovasc Pharmacol. 2003 May;41(5):699-705. doi: 10.1097/00005344-200305000-00005.
8
Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging.
Circulation. 2003 Apr 22;107(15):1991-7. doi: 10.1161/01.CIR.0000065637.10517.A0. Epub 2003 Apr 21.
9
Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase.
Circulation. 2002 Dec 10;106(24):3073-8. doi: 10.1161/01.cir.0000041431.57222.af.
10
Allopurinol improves endothelial dysfunction in chronic heart failure.
Circulation. 2002 Jul 9;106(2):221-6. doi: 10.1161/01.cir.0000022140.61460.1d.
Zotero 插件